• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性抑郁症:当缓解难以实现时的临床和研究路线图。

Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive.

机构信息

1 Duke-National University of Singapore Medical School, Singapore.

2 Department of Psychiatry & Behavioral Sciences, Duke University, School of Medicine, Durham, NC, USA.

出版信息

Aust N Z J Psychiatry. 2019 Feb;53(2):109-118. doi: 10.1177/0004867418808585. Epub 2018 Oct 31.

DOI:10.1177/0004867418808585
PMID:30378447
Abstract

OBJECTIVES

The report considers the pros and cons of the most commonly used conceptual model that forms the basis for most clinical practice guidelines for depression. This model promotes the attainment of sustained symptom remission as the treatment goal based on its well-established prognostic and functional importance. Sustained remission is very unlikely, however, after multiple treatment attempts. Our current model propels many clinicians to continue to change or add treatments despite little chance for remission or full functional restoration and despite the increasing risk of more adverse events from polypharmacy. An alternative 'difficult-to-treat depression' model is presented and considered. It accepts that the treatment aims for some depressed patients may shift to optimal symptom control rather than remission. When difficult-to-treat depression is suspected, the many treatable causes of persistent depression must be assessed and addressed (given the importance of remission when attainable) before difficult-to-treat depression can be ascribed. The clinical and research implications of the difficult-to-treat depression model are discussed.

CONCLUSION

Suspected difficult-to-treat depression provides a practical basis for considering when to conduct a comprehensive evaluation. Once difficult-to-treat depression is confirmed, treatment may better focus on optimal disease management (symptom control and functional improvement).

摘要

目的

本报告考虑了最常用的概念模型的优缺点,该模型是大多数抑郁症临床实践指南的基础。该模型基于其明确的预后和功能重要性,提倡将持续缓解症状作为治疗目标。然而,在多次治疗尝试后,持续缓解的可能性非常小。我们目前的模型促使许多临床医生继续改变或添加治疗方法,尽管缓解或完全功能恢复的机会很小,而且由于药物联合使用的风险增加,出现更多不良事件的风险也会增加。提出并考虑了一种替代的“难治性抑郁症”模型。它接受这样一个事实,即一些抑郁症患者的治疗目标可能会转向最佳症状控制而不是缓解。当怀疑为难治性抑郁症时,必须评估和解决持续抑郁的许多可治疗原因(因为缓解在可达到时非常重要),然后才能归因于难治性抑郁症。讨论了难治性抑郁症模型的临床和研究意义。

结论

疑似难治性抑郁症为何时进行全面评估提供了一个实用的基础。一旦确诊为难治性抑郁症,治疗可能更好地侧重于最佳疾病管理(症状控制和功能改善)。

相似文献

1
Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive.难治性抑郁症:当缓解难以实现时的临床和研究路线图。
Aust N Z J Psychiatry. 2019 Feb;53(2):109-118. doi: 10.1177/0004867418808585. Epub 2018 Oct 31.
2
The identification, assessment and management of difficult-to-treat depression: An international consensus statement.难治性抑郁症的识别、评估与管理:一项国际共识声明。
J Affect Disord. 2020 Apr 15;267:264-282. doi: 10.1016/j.jad.2020.02.023. Epub 2020 Feb 7.
3
Management of treatment-resistant depression.治疗抵抗性抑郁症的管理。
Psychiatr Clin North Am. 2012 Mar;35(1):249-65. doi: 10.1016/j.psc.2011.11.004. Epub 2011 Dec 21.
4
Nonsomatic treatment of depression.抑郁症的非躯体治疗。
Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. doi: 10.1016/s1056-4993(02)00009-3.
5
A revisionist model for treatment-resistant and difficult-to-treat depression.一种针对治疗抵抗和难治性抑郁症的修正主义模型。
Aust N Z J Psychiatry. 2024 Jun;58(6):460-466. doi: 10.1177/00048674241240600. Epub 2024 Mar 27.
6
Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders.针对难治性情感障碍的强化住院多学科干预后的长期症状及功能转归
J Affect Disord. 2014 Sep;166:334-42. doi: 10.1016/j.jad.2014.05.013. Epub 2014 May 21.
7
Assessing the risk factors for difficult-to-treat depression and treatment-resistant depression.评估难治性抑郁症和治疗抵抗性抑郁症的风险因素。
J Clin Psychiatry. 2016 Feb;77 Suppl 1:4-8. doi: 10.4088/JCP.14077su1c.01.
8
Prediction of longer-term outcome of treatment-resistant depression in tertiary care.三级护理中治疗抵抗性抑郁症的长期预后预测。
Br J Psychiatry. 2012 Nov;201(5):369-75. doi: 10.1192/bjp.bp.111.102665. Epub 2012 Sep 6.
9
[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].[重度抑郁症治疗后的残留症状:在城市进行的门诊观察实践]
Encephale. 2003 Sep-Oct;29(5):438-44.
10
Using mechanism of action to choose medications for treatment-resistant depression.利用作用机制选择难治性抑郁症的治疗药物。
J Clin Psychiatry. 2015 Sep;76(9):e1147. doi: 10.4088/JCP.14052wc1c.

引用本文的文献

1
Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.难治性抑郁症与鼻内用艾司氯胺酮:西班牙关于理论方面的共识
Front Psychiatry. 2025 Aug 4;16:1623659. doi: 10.3389/fpsyt.2025.1623659. eCollection 2025.
2
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression.对症状、功能及生活质量作为难治性抑郁症联合临床结局领域的研究。
J Mood Anxiety Disord. 2025 Apr 14;10:100121. doi: 10.1016/j.xjmad.2025.100121. eCollection 2025 Jun.
3
Treatment resistant depression: Socio-demographic characteristics, comorbidity and treatment patterns from the All of Us Research Program.
难治性抑郁症:来自“我们所有人”研究项目的社会人口学特征、合并症及治疗模式
J Affect Disord. 2025 Jul 9;390:119858. doi: 10.1016/j.jad.2025.119858.
4
Perspectives on Personalized Treatment in Difficult-to-Treat Depression: A Case Report.难治性抑郁症个性化治疗的观点:一例病例报告
Case Rep Psychiatry. 2025 May 6;2025:5538951. doi: 10.1155/crps/5538951. eCollection 2025.
5
Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity.二十味肉豆蔻丸及其活性成分五味子酯甲的抗抑郁作用:涉及氧化应激、神经炎症和突触可塑性的多种机制
Transl Psychiatry. 2025 May 9;15(1):163. doi: 10.1038/s41398-025-03378-4.
6
Difficult-to-Treat Anxiety: A Neurocomputational Framework.难治性焦虑:一种神经计算框架
Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Mar 28. doi: 10.1016/j.bpsc.2025.03.008.
7
Process-based therapy vs. routine-CBT for difficult-to-treat mood and anxiety disorders: study protocol for a randomized controlled trial.基于过程的疗法与常规认知行为疗法治疗难治性情绪和焦虑障碍的比较:一项随机对照试验的研究方案
Trials. 2024 Dec 19;25(1):838. doi: 10.1186/s13063-024-08689-3.
8
Comorbid anxiety, loneliness, and chronic pain as predictors of intervention outcomes for subclinical depressive symptoms in older adults: evidence from a large community-based study in Hong Kong.焦虑、孤独和慢性疼痛共病与老年人亚临床抑郁症状干预结果的关系:来自香港一项大型社区研究的证据。
BMC Psychiatry. 2024 Nov 21;24(1):839. doi: 10.1186/s12888-024-06281-2.
9
Sociodemographic and clinical characteristics of suspected difficult-to-treat depression.疑似难治性抑郁症的社会人口学和临床特征
Front Psychiatry. 2024 Aug 21;15:1371242. doi: 10.3389/fpsyt.2024.1371242. eCollection 2024.
10
Long-Term Immunomodulatory Impact of VNS on Peripheral Cytokine Profiles and Its Relationship with Clinical Response in Difficult-to-Treat Depression (DTD).迷走神经刺激(VNS)对难治性抑郁症(DTD)外周细胞因子谱的长期免疫调节作用及其与临床反应的关系
Int J Mol Sci. 2024 Apr 10;25(8):4196. doi: 10.3390/ijms25084196.